Alkermes - 28 Year Stock Price History | ALKS

Historical daily share price chart and data for Alkermes since 1991 adjusted for splits. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Alkermes as of March 21, 2019 is 34.94.
Alkermes Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 32.8516 29.1100 35.0100 28.4000 34.9400 18.40%
2018 45.9911 55.2200 67.2600 27.9400 29.5100 -46.08%
2017 54.8201 56.1000 61.6600 47.6900 54.7300 -1.53%
2016 45.4797 74.8300 75.2700 29.0500 55.5800 -29.98%
2015 66.3880 58.2400 80.1400 55.0800 79.3800 35.55%
2014 47.3686 40.2400 58.8800 40.0700 58.5600 44.02%
2013 30.2678 19.2800 41.1200 19.2800 40.6600 119.55%
2012 18.1842 17.3400 20.8800 15.1200 18.5200 6.68%
2011 15.4301 12.5500 19.5200 12.1400 17.3600 41.37%
2010 12.4457 9.7100 15.9200 9.6900 12.2800 30.50%
2009 9.6079 10.7100 13.1300 7.5600 9.4100 -11.64%
2008 12.2140 15.1000 16.8900 6.1000 10.6500 -31.69%
2007 15.7875 13.0900 18.5600 12.7600 15.5900 16.60%
2006 18.9792 20.5200 26.7100 13.1800 13.3700 -30.07%
2005 14.4015 14.0100 19.6600 10.0100 19.1200 35.70%
2004 13.3925 13.9700 16.8600 8.5100 14.0900 4.37%
2003 11.0876 6.6600 15.5600 6.5200 13.5000 115.31%
2002 15.1033 25.7500 30.3400 3.7800 6.2700 -76.21%
2001 26.8799 27.6300 37.1000 17.5000 26.3600 -16.00%
2000 41.5542 25.5000 98.0500 23.6250 31.3800 27.74%
1999 15.7511 11.6900 26.8150 11.4400 24.5650 121.41%
1998 9.9991 9.9400 13.3750 5.3150 11.0950 11.62%
1997 9.5169 11.1900 14.6900 5.1900 9.9400 -14.49%
1996 6.2174 3.7500 12.1250 3.7500 11.6250 192.89%
1995 2.4000 1.0315 4.3125 1.0000 3.9690 273.55%
1994 2.4714 3.6875 4.5000 1.0625 1.0625 -69.64%
1993 4.1401 4.5000 5.5000 3.1250 3.5000 -17.65%
1992 6.0673 9.0000 14.1900 2.7500 4.2500 -52.78%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $5.391B $1.094B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $118.930B 13.26
Gilead Sciences (GILD) United States $82.398B 10.49
Biogen (BIIB) United States $63.063B 12.22
Celgene (CELG) United States $62.067B 11.48
Illumina (ILMN) United States $46.349B 55.12
Vertex Pharmaceuticals (VRTX) United States $46.013B 61.64
Regeneron Pharmaceuticals (REGN) United States $44.311B 20.58
Alexion Pharmaceuticals (ALXN) United States $29.422B 18.24
Incyte (INCY) United States $18.475B 172.62
BioMarin Pharmaceutical (BMRN) United States $16.046B 0.00
Seattle Genetics (SGEN) United States $11.684B 0.00
Exact Sciences (EXAS) United States $11.379B 0.00
Alnylam Pharmaceuticals (ALNY) United States $9.423B 0.00
Bio-Rad Laboratories (BIO.B) United States $9.298B 53.05
QIAGEN (QGEN) Netherlands $9.023B 29.86
Sarepta Therapeutics (SRPT) United States $8.830B 0.00
Bluebird Bio (BLUE) United States $8.439B 0.00
BeiGene (BGNE) Cayman Islands $7.982B 0.00
Guardant Health (GH) United States $7.569B 0.00
Bio-Techne Corp (TECH) United States $7.497B 50.51
Exelixis (EXEL) United States $7.317B 17.05
Moderna (MRNA) United States $6.580B 0.00
Amarin (AMRN) Ireland $6.139B 0.00
Array BioPharma (ARRY) United States $5.335B 0.00
Galapagos (GLPG) Belgium $5.290B 0.00
Ascendis Pharma (ASND) Denmark $5.228B 0.00
Horizon Pharma Public (HZNP) Ireland $4.729B 15.23
Spark Therapeutics (ONCE) United States $4.309B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.246B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.773B 0.00
Blueprint Medicines (BPMC) United States $3.677B 0.00
Immunomedics (IMMU) United States $3.494B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.490B 0.00
China Biologic Products (CBPO) China $3.441B 21.32
Intercept Pharmaceuticals (ICPT) United States $3.358B 0.00
Allogene Therapeutics (ALLO) United States $3.154B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.026B 0.00
Amicus Therapeutics (FOLD) United States $2.991B 0.00
Global Blood Therapeutics (GBT) United States $2.881B 0.00
Reata Pharmaceuticals (RETA) United States $2.710B 0.00
Genomic Health (GHDX) United States $2.709B 69.26
Repligen (RGEN) United States $2.612B 80.38
Akcea Therapeutics (AKCA) United States $2.587B 0.00
Mirati Therapeutics (MRTX) United States $2.566B 0.00
Ligand Pharmaceuticals (LGND) United States $2.529B 18.89
UniQure (QURE) Netherlands $2.477B 0.00
Emergent Biosolutions (EBS) United States $2.469B 20.61
Myriad Genetics (MYGN) United States $2.421B 24.66
Halozyme Therapeutics (HALO) United States $2.399B 0.00
Acceleron Pharma (XLRN) United States $2.338B 0.00
Insmed (INSM) United States $2.223B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $2.209B 0.00
REGENXBIO (RGNX) United States $2.207B 23.04
Arena Pharmaceuticals (ARNA) United States $2.203B 0.00
MyoKardia (MYOK) United States $2.197B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $2.181B 0.00
Denali Therapeutics (DNLI) United States $2.083B 0.00
Medicines (MDCO) United States $1.998B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $1.940B 0.00
AnaptysBio (ANAB) United States $1.915B 0.00
NeoGenomics (NEO) United States $1.838B 149.54
Atara Biotherapeutics (ATRA) United States $1.794B 0.00
Zai Lab Unsponsored ADR (ZLAB) China $1.745B 0.00
Myovant Sciences (MYOV) United Kingdom $1.720B 0.00
Audentes Therapeutics (BOLD) United States $1.644B 0.00
Allakos (ALLK) United States $1.641B 0.00
Puma Biotechnology (PBYI) United States $1.520B 0.00
WAVE Life Sciences (WVE) Singapore $1.509B 0.00
GOSSAMER BIO (GOSS) United States $1.472B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.452B 0.00
Innoviva (INVA) United States $1.409B 3.88
Momenta Pharmaceuticals (MNTA) United States $1.356B 0.00
Clovis Oncology (CLVS) United States $1.338B 0.00
Aimmune Therapeutics (AIMT) United States $1.315B 0.00
Rubius Therapeutics (RUBY) United States $1.306B 0.00
Cambrex (CBM) United States $1.299B 13.99
ALECTOR INC (ALEC) United States $1.292B 0.00
Lion Biotechnologies (IOVA) United States $1.237B 0.00
Apellis Pharmaceuticals (APLS) United States $1.206B 0.00
Editas Medicine (EDIT) United States $1.184B 0.00
Fate Therapeutics (FATE) United States $1.147B 0.00
Codexis (CDXS) United States $1.141B 0.00
Epizyme (EPZM) United States $1.085B 0.00
InflaRx (IFRX) Germany $1.081B 0.00
RA PHARMCTL INC (RARX) United States $1.057B 0.00
Coherus BioSciences (CHRS) United States $1.045B 0.00
Rhythm Pharmaceuticals (RYTM) United States $1.041B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.987B 0.00
Clementia Pharmaceuticals (CMTA) Canada $0.985B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.980B 0.00
Retrophin (RTRX) United States $0.977B 0.00
Sangamo Therapeutics (SGMO) United States $0.975B 0.00
Deciphera Pharmaceuticals (DCPH) United States $0.943B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.942B 38.08
Dicerna Pharmaceuticals (DRNA) United States $0.929B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.922B 0.00
Principia Biopharma (PRNB) United States $0.869B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.833B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.823B 0.00
Athenex (ATNX) United States $0.814B 0.00
Vericel (VCEL) United States $0.810B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.800B 0.00
Cellectis (CLLS) France $0.794B 0.00
Eidos Therapeutics (EIDX) United States $0.770B 0.00
Intellia Therapeutics (NTLA) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.766B 0.00
ANI Pharmaceuticals (ANIP) United States $0.764B 13.98
Nightstar Therapeutics Sponsored ADR (NITE) United Kingdom $0.708B 0.00
Revance Therapeutics (RVNC) United States $0.699B 0.00
Intra-Cellular Therapies (ITCI) United States $0.694B 0.00
Synthorx (THOR) United States $0.670B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.670B 0.00
Osiris Therapeutics (OSIR) United States $0.664B 0.00
Twist Bioscience (TWST) United States $0.652B 0.00
Acorda Therapeutics (ACOR) United States $0.652B 8.45
Heska (HSKA) United States $0.647B 57.99
Magenta Therapeutics (MGTA) United States $0.597B 0.00
Viking Therapeutics (VKTX) United States $0.595B 0.00
Kura Oncology (KURA) United States $0.586B 0.00
ObsEva SA (OBSV) Switzerland $0.581B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.580B 0.00
Stemline Therapeutics (STML) United States $0.566B 0.00
G1 THERAPEUTICS (GTHX) United States $0.562B 0.00
Cytokineticsorporated (CYTK) United States $0.559B 0.00
Arvinas (ARVN) United States $0.546B 0.00
Zealand Pharma (ZEAL) Denmark $0.545B 6.00
Prothena (PRTA) Ireland $0.544B 0.00
MeiraGTx Holdings (MGTX) United States $0.539B 0.00
UROGEN PHARMA (URGN) Israel $0.516B 0.00
NuCana Sponsored ADR (NCNA) United Kingdom $0.516B 0.00
Arcus Biosciences (RCUS) United States $0.514B 0.00
Scholar Rock Holding (SRRK) United States $0.498B 0.00
Zymeworks (ZYME) Canada $0.494B 0.00
DBV Technologies (DBVT) France $0.486B 0.00
CytomX Therapeutics (CTMX) United States $0.484B 0.00
Dynavax Technologies (DVAX) United States $0.482B 0.00
PDL BioPharma (PDLI) United States $0.474B 10.57
Five Prime Therapeutics (FPRX) United States $0.466B 0.00
Mesoblast (MESO) Australia $0.451B 0.00
Replimune (REPL) United States $0.447B 0.00
AVROBIO (AVRO) United States $0.446B 0.00
Senesco Technologies (ELOX) United States $0.436B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.433B 0.00
Sorrento Therapeutics (SRNE) United States $0.427B 0.00
Anika Therapeutics (ANIK) United States $0.424B 16.03
Achillion Pharmaceuticals (ACHN) United States $0.415B 0.00
MannKind (MNKD) United States $0.414B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.407B 0.00
BeyondSpring (BYSI) United States $0.400B 0.00
Axsome Therapeutics (AXSM) United States $0.400B 0.00
XBiotech (XBIT) United States $0.397B 0.00
Agenus (AGEN) United States $0.389B 0.00
Solid Biosciences (SLDB) United States $0.378B 0.00
UNITY Biotechnology (UBX) $0.378B 0.00
Abeona Therapeutics (ABEO) United States $0.377B 0.00
BioDelivery Sciences (BDSI) United States $0.374B 0.00
STEALTH BIOTHER (MITO) United States $0.373B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
Adverum Biotechnologies (ADVM) United States $0.369B 0.00
Albireo Pharma (ALBO) United States $0.368B 0.00
Kadmon Holdings (KDMN) United States $0.363B 0.00
MediciNova (MNOV) United States $0.360B 0.00
Urovant Sciences (UROV) United States $0.353B 0.00
Inovio Pharmaceuticals (INO) United States $0.351B 0.00
Kezar Life Sciences (KZR) United States $0.351B 0.00
Gritstone Oncology (GRTS) United States $0.340B 0.00
Kindred Biosciences (KIN) United States $0.338B 0.00
Geron (GERN) United States $0.330B 0.00
Cellular Biomedicine (CBMG) United States $0.329B 0.00
OSMOTICA PHARM (OSMT) United States $0.329B 0.00
Krystal Biotech (KRYS) United States $0.320B 0.00
Aduro Biotech (ADRO) United States $0.312B 0.00
Protagonist Therapeutics (PTGX) United States $0.307B 0.00
AC Immune SA (ACIU) Switzerland $0.306B 0.00
Syros Pharmaceuticals (SYRS) United States $0.300B 0.00
Strongbridge Biopharma (SBBP) United States $0.300B 0.00
Merus (MRUS) Netherlands $0.292B 0.00
Constellation Pharmaceuticals (CNST) United States $0.292B 0.00
Biofrontera AG Sponsored ADR (BFRA) Germany $0.285B 0.00
Gamida Cell (GMDA) Israel $0.284B 0.00
Novavax (NVAX) United States $0.283B 0.00
Kala Pharmaceuticals (KALA) United States $0.279B 0.00
Enochian BioSciences (ENOB) United States $0.278B 0.00
Seres Therapeutics (MCRB) United States $0.277B 0.00
Evelo Biosciences (EVLO) United States $0.269B 0.00
Verastem (VSTM) United States $0.264B 0.00
Sutro Biopharma (STRO) United States $0.258B 0.00
Kodiak Sciences (KOD) United States $0.257B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.256B 0.00
TOCAGEN INC (TOCA) United States $0.251B 0.00
Cerecor (CERC) United States $0.250B 0.00
BioTime (BTX) United States $0.245B 0.00
Avid Bioservices (CDMO) United States $0.244B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.244B 0.00
Kamada (KMDA) Israel $0.238B 10.74
Aeglea BioTherapeutics (AGLE) United States $0.233B 0.00
Athersys (ATHX) United States $0.231B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.231B 0.00
Spero Therapeutics (SPRO) United States $0.226B 0.00
Celyad SA (CYAD) Belgium $0.223B 0.00
Axovant Sciences (AXGT) United Kingdom $0.222B 0.00
Intec Pharma (NTEC) Israel $0.222B 0.00
Proteostasis Therapeutics (PTI) United States $0.221B 0.00
Mersana Therapeutics (MRSN) United States $0.219B 0.00
LogicBio Therapeutics (LOGC) United States $0.219B 0.00
ChromaDex (CDXC) United States $0.215B 0.00
Liquidia Technologies (LQDA) United States $0.213B 0.00
Arbutus Biopharma (ABUS) Canada $0.210B 0.00
Palatin Technologies (PTN) United States $0.205B 101.00
Celcuity (CELC) United States $0.203B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.202B 0.00
Synlogic (SYBX) United States $0.201B 0.00
VBI Vaccines (VBIV) United States $0.194B 0.00
Compugen (CGEN) Israel $0.193B 0.00
Cue Biopharma (CUE) United States $0.193B 0.00
Pfenex (PFNX) United States $0.192B 0.00
OvaScience (MLND) United States $0.188B 0.00
Menlo Therapeutics (MNLO) United States $0.182B 0.00
CorMedix Inc (CRMD) United States $0.182B 0.00
ADMA Biologics Inc (ADMA) United States $0.181B 0.00
ResTORbio (TORC) United States $0.178B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.177B 0.00
Trevena (TRVN) United States $0.171B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.159B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.154B 0.00
BioXcel Therapeutics (BTAI) United States $0.154B 0.00
PHASEBIO PHARMA (PHAS) United States $0.153B 0.00
Chiasma (CHMA) United States $0.152B 0.00
Allena Pharmaceuticals (ALNA) United States $0.150B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.144B 0.00
Anavex Life Sciences (AVXL) United States $0.141B 0.00
Unum Therapeutics (UMRX) United States $0.139B 0.00
Cohbar (CWBR) United States $0.138B 0.00
Eton Pharmaceuticals (ETON) United States $0.137B 0.00
Aptinyx (APTX) United States $0.134B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.130B 0.00
Organovo Holdings (ONVO) United States $0.129B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.128B 0.00
Equillium (EQ) United States $0.127B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.127B 0.00
Enzo Biochem (ENZ) United States $0.124B 0.00
Fortress Biotech (FBIO) United States $0.122B 0.00
Selecta Biosciences (SELB) United States $0.121B 0.00
XOMA (XOMA) United States $0.120B 0.00
Catalyst Biosciences (CBIO) United States $0.116B 0.00
Pluristem Therapeutics (PSTI) Israel $0.115B 0.00
Mustang Bio (MBIO) United States $0.114B 0.00
Checkpoint Therapeutics (CKPT) United States $0.111B 0.00
VolitionRX (VNRX) Singapore $0.110B 0.00
Signal Genetics (MGEN) United States $0.105B 0.00
NantKwest (NK) United States $0.104B 0.00
Neothetics (EVFM) United States $0.104B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.097B 0.00
Cel-Sci (CVM) United States $0.095B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.093B 0.00
ARAVIVE, INC (ARAV) United States $0.092B 0.00
Provention Bio (PRVB) United States $0.090B 0.00
Aptose Biosciences (APTO) Canada $0.089B 0.00
Idera Pharmaceuticals (IDRA) United States $0.087B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.086B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.086B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.086B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.084B 0.00
VTv Therapeutics (VTVT) United States $0.084B 0.00
Cocrystal Pharma (COCP) United States $0.083B 93.00
Brainstorm Cell Therapeutics (BCLI) United States $0.083B 0.00
Oncobiologics (OTLK) United States $0.081B 0.00
Alimera Sciences (ALIM) United States $0.080B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.080B 0.00
NewLink Genetics (NLNK) United States $0.079B 0.00
Orgenesis (ORGS) United States $0.079B 0.00
Applied Genetic Technologies (AGTC) United States $0.077B 0.00
INMUNE BIO INC (INMB) United States $0.077B 0.00
SESEN BIO, INC (SESN) United States $0.075B 0.00
OVID THERAPEUTC (OVID) United States $0.073B 0.00
Cidara Therapeutics (CDTX) United States $0.071B 0.00
Protalix BioTherapeutics (PLX) Israel $0.071B 0.00
AEterna Zentaris (AEZS) United States $0.069B 13.16
Prima BioMed (IMMP) Australia $0.066B 0.00
Eyenovia (EYEN) United States $0.065B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.064B 0.00
Ophthotech (OPHT) United States $0.064B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.063B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.062B 0.00
Proteon Therapeutics (PRTO) United States $0.062B 0.00
Vascular Biogenics (VBLT) Israel $0.061B 0.00
Celldex Therapeutics (CLDX) United States $0.060B 0.00
Alcobra (ARCT) United States $0.059B 0.00
ScPharmaceuticals (SCPH) United States $0.058B 0.00
Zosano Pharma (ZSAN) United States $0.057B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.057B 0.00
Arsanis (XFOR) United States $0.055B 0.00
VistaGen Therapeutics (VTGN) United States $0.054B 0.00
Clearside Biomedical (CLSD) United States $0.053B 0.00
ANCHIANO THERAP (ANCN) Israel $0.050B 0.00
Vaccinex (VCNX) United States $0.049B 0.00
Bellerophon Therapeutics (BLPH) United States $0.049B 0.00
Evogene (EVGN) Israel $0.049B 0.00
VIVUS (VVUS) United States $0.049B 0.00
Entera Bio (ENTX) Israel $0.048B 0.00
Bionano Genomics (BNGO) United States $0.048B 0.00
Curis (CRIS) United States $0.046B 0.00
TRACON Pharmaceuticals (TCON) United States $0.046B 0.00
Leap Therapeutics (LPTX) United States $0.043B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.043B 0.00
Celsion (CLSN) United States $0.041B 0.00
DiaMedica Therapeutics (DMAC) United States $0.040B 0.00
AZURRX BIOPHARM (AZRX) United States $0.039B 0.00
Moleculin Biotech (MBRX) United States $0.038B 0.00
Motif Bio Plc (MTFB) United States $0.037B 0.00
OncoMed Pharmaceuticals (OMED) United States $0.036B 0.00
Caladrius Biosciences (CLBS) United States $0.036B 0.00
Aptevo Therapeutics (APVO) United States $0.036B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.035B 0.00
OncoSec Medical (ONCS) United States $0.035B 0.00
AquaBounty Technologies (AQB) United States $0.035B 0.00
Sophiris Bio (SPHS) United States $0.034B 0.00
Advaxis (ADXS) United States $0.034B 0.00
Oncolytics Biotech (ONCY) Canada $0.033B 0.00
GTx (GTXI) United States $0.031B 0.00
Aileron Therapeutics (ALRN) United States $0.031B 0.00
Galena Biopharma (SLS) United States $0.030B 0.00
BioPharmX (BPMX) United States $0.029B 0.00
Adial Pharmaceuticals (ADIL) United States $0.028B 0.00
GENPREX INC (GNPX) United States $0.028B 0.00
Rexahn Pharmaceuticals (RNN) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.026B 0.00
Vical (VICL) United States $0.026B 0.00
Oragenics (OGEN) United States $0.026B 0.00
Aytu Bioscience (AYTU) United States $0.025B 0.00
CytRx (CYTR) United States $0.025B 0.00
IMMURON LTD (IMRN) Australia $0.025B 0.00
Fibrocell Science Inc (FCSC) United States $0.023B 0.00
Novelion Therapeutics (NVLN) Canada $0.023B 0.00
Benitec Biopharma (BNTC) Australia $0.022B 0.00
Dare Bioscience (DARE) United States $0.020B 0.00
Cleveland BioLabs (CBLI) United States $0.019B 0.00
Novogen (KZIA) Australia $0.018B 0.00
Gemphire Therapeutics (GEMP) United States $0.018B 0.00
TrovaGene (TROV) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
Soligenix (SNGX) United States $0.017B 0.00
RestorGenex (DFFN) United States $0.016B 0.00
Prana Biotechnology (PRAN) Australia $0.015B 0.00
Therapix Biosciences (TRPX) Israel $0.015B 7.54
Genetic Technologies (GENE) Australia $0.015B 0.00
ATyr Pharma (LIFE) United States $0.015B 0.00
Apricus Biosciences (SEEL) United States $0.014B 0.00
Alliqua BioMedical (ALQA) United States $0.014B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.013B 0.00
Pulmatrix (PULM) United States $0.012B 0.00
Neuralstem (CUR) United States $0.012B 0.00
Synthetic Biologics (SYN) United States $0.012B 0.00
AmpliPhi Biosciences (APHB) United States $0.010B 0.00
MYOS RENS Technology (MYOS) United States $0.010B 0.00
Vital Therapies (VTL) United States $0.009B 0.00
Histogenics (HSGX) United States $0.009B 0.00
Hemispherx BioPharma (HEB) United States $0.009B 0.00
ARCA Biopharma (ABIO) United States $0.008B 0.00
Flex Pharma (FLKS) United States $0.007B 0.00
Stellar Biotechnologies (SBOT) United States $0.006B 0.00
Cellect Biotechnology (APOP) Israel $0.006B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.005B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.004B 0.00
Tenax Therapeutics (TENX) United States $0.003B 0.00
HOTH THERAPEUTC (HOTH) United States $0.000B 0.00